D. Dhanoa

Review: Cardiovascular & Renal Nouropeptide Y: a promising therapeutic target

D. Dhanoa, 1995 .

Synthesis and insecticidal activity of fluorinated 2-(2,6-dichloro-4-trifluoromethylphenyl)-2,4,5,6-tetrahydrocyclopentapyrazoles.

S. Meegalla, D. Doller, R. Soll, 2006, Bioorganic & medicinal chemistry letters.

Synthesis and GABA receptor potency of 3-thiomethyl-4-(hetero)aryl-5-amino-1-phenylpyrazoles.

S. Meegalla, D. Doller, R. Soll, 2004, Bioorganic & medicinal chemistry letters.

Discovery of potent and selective small molecule NPY Y5 receptor antagonists.

I. Islam, J. Salon, M. Walker, 2002, Bioorganic & medicinal chemistry letters.

Design, synthesis and SAR of a series of 2-substituted 4-amino-quinazoline neuropeptide Y Y5 receptor antagonists.

S. Whitebread, I. Islam, J. Zhang, 2000, Bioorganic & medicinal chemistry letters.

Modeling the G-protein-coupled neuropeptide Y Y1 receptor agonist and antagonist binding sites.

T. Branchek, R. Weinshank, P. Vaysse, 1997, Protein engineering.

An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression.

Raphael Nudelman, Yael Marantz, Alexander Heifetz, 2006, Journal of medicinal chemistry.

5-amino-1-(2,6-dichloro-4-trifluoromethyl-phenyl)-3-[3H3]-methylsulfanyl-1H-pyrazole-4-carbonitrile (CTOM): synthesis and characterization of a novel and selective insect GABA receptor radioligand.

S. Meegalla, D. Doller, R. Soll, 2003, Bioorganic & medicinal chemistry letters.